DE60128906D1 - Edg8-rezeptor, dessen herstellung und verwendung - Google Patents

Edg8-rezeptor, dessen herstellung und verwendung

Info

Publication number
DE60128906D1
DE60128906D1 DE60128906T DE60128906T DE60128906D1 DE 60128906 D1 DE60128906 D1 DE 60128906D1 DE 60128906 T DE60128906 T DE 60128906T DE 60128906 T DE60128906 T DE 60128906T DE 60128906 D1 DE60128906 D1 DE 60128906D1
Authority
DE
Germany
Prior art keywords
preparation
receptor
polynucleotides
edg8
edg8 receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128906T
Other languages
English (en)
Other versions
DE60128906T2 (de
Inventor
Evi Kostenis
Johann Gassenhuber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00108858A external-priority patent/EP1149907A1/de
Priority claimed from EP00116589A external-priority patent/EP1178110A1/de
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Application granted granted Critical
Publication of DE60128906D1 publication Critical patent/DE60128906D1/de
Publication of DE60128906T2 publication Critical patent/DE60128906T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
DE60128906T 2000-04-26 2001-04-14 Edg8-rezeptor, dessen herstellung und verwendung Expired - Lifetime DE60128906T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00108858A EP1149907A1 (de) 2000-04-26 2000-04-26 EDG8 Rezeptor, dessen Herstellung und Verwendung
EP00108858 2000-04-26
EP00116589 2000-08-01
EP00116589A EP1178110A1 (de) 2000-08-01 2000-08-01 EDG8 Rezeptor für Sphingosine 1-Phosphate , dessen Herstellung und Anwendung
PCT/EP2001/004283 WO2001081573A1 (en) 2000-04-26 2001-04-14 Edg8 receptor, its preparation and use

Publications (2)

Publication Number Publication Date
DE60128906D1 true DE60128906D1 (de) 2007-07-26
DE60128906T2 DE60128906T2 (de) 2008-02-07

Family

ID=26070860

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128906T Expired - Lifetime DE60128906T2 (de) 2000-04-26 2001-04-14 Edg8-rezeptor, dessen herstellung und verwendung

Country Status (14)

Country Link
US (2) US20020099191A1 (de)
EP (1) EP1278850B1 (de)
JP (1) JP5139617B2 (de)
KR (1) KR100790329B1 (de)
AT (1) ATE364697T1 (de)
AU (2) AU2001270489B2 (de)
BR (1) BR0110248A (de)
CA (1) CA2406725C (de)
DE (1) DE60128906T2 (de)
IL (2) IL152378A0 (de)
MX (1) MXPA02010241A (de)
NO (1) NO331197B1 (de)
NZ (1) NZ522215A (de)
WO (1) WO2001081573A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
AU2001291653A1 (en) * 2000-10-02 2002-04-15 Novo-Nordisk A/S Industrial-scale serum-free production of recombinant factor vii in mammalian cells
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
JP2005522184A (ja) * 2001-07-20 2005-07-28 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規のｇタンパク質共役受容体ｇａｖｅ８
WO2004044587A2 (en) * 2002-11-13 2004-05-27 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5)
WO2005009469A1 (ja) * 2003-07-28 2005-02-03 Sumitomo Pharmaceuticals Co., Ltd. 新規血糖調節薬及びそのスクリーニング方法
WO2006014808A1 (en) * 2004-07-27 2006-02-09 Merck & Co., Inc. Canis sphingosine 1-phosphate receptor isoform 5
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
US9952202B2 (en) 2013-03-14 2018-04-24 Galapagos Nv Methods of identifying compounds for the treatment of fibrosis by using S1PR5

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO1999019513A2 (en) * 1997-10-10 1999-04-22 Lxr Biotechnology, Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
JP2002531057A (ja) * 1998-08-19 2002-09-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｅｄｇ受容体ファミリーに関連したｇタンパク質結合受容体である１４２７４受容体
WO2001004139A2 (en) * 1999-07-13 2001-01-18 Smithkline Beecham Corporation Human axor29 receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
EP1278850A1 (de) 2003-01-29
JP2003530882A (ja) 2003-10-21
NO331197B1 (no) 2011-10-31
MXPA02010241A (es) 2004-09-06
US20020099191A1 (en) 2002-07-25
JP5139617B2 (ja) 2013-02-06
IL152378A0 (en) 2003-05-29
CA2406725A1 (en) 2001-11-01
KR20020097234A (ko) 2002-12-31
DE60128906T2 (de) 2008-02-07
AU2001270489B2 (en) 2007-03-15
IL152378A (en) 2010-12-30
BR0110248A (pt) 2003-01-07
US7141383B2 (en) 2006-11-28
KR100790329B1 (ko) 2008-01-02
US20030219874A1 (en) 2003-11-27
NZ522215A (en) 2004-05-28
WO2001081573A1 (en) 2001-11-01
NO20025152D0 (no) 2002-10-25
ATE364697T1 (de) 2007-07-15
AU7048901A (en) 2001-11-07
EP1278850B1 (de) 2007-06-13
NO20025152L (no) 2002-12-13
CA2406725C (en) 2013-01-15

Similar Documents

Publication Publication Date Title
BG108495A (en) 5-ht receptor ligands and uses thereof
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
TR200401871T4 (tr) Değiştirilen oktanoil amitlerin (octanoyl amides) hazırlanması
AP2004002982A0 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain.
WO2005000820A3 (fr) Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
MXPA03010144A (es) Proteinas de agutinacion al peptido beta-amiloide y polinucleotidos que las codifican.
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
MXPA03002971A (es) Receptores de hematopoyetina hpr1 y hpr2.
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
ATE363531T1 (de) Claudin polypeptide
FR2852229B1 (fr) Prothese totale d'epaule.
TR200002896T2 (tr) Kalsilitik Bileşimler
DK1141286T3 (da) Kæde af cytokinreceptorer
ATE364697T1 (de) Edg8-rezeptor, dessen herstellung und verwendung
DE60304695D1 (de) 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
EA200601220A1 (ru) Анти-trkc антитела-агонисты и способы их применения
TR200103448T2 (tr) IL-8 reseptör antagonistleri.
DE60224667D1 (de) Perylenequinonen zur anwendung als sonosensitizer
TNSN06272A1 (en) Use of antagonists of the cb1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
WO2005046602A3 (en) Vegf receptor antagonists
WO2003074656A3 (en) Rank-ligand-induced sodium/proton antiporter polypeptides

Legal Events

Date Code Title Description
8364 No opposition during term of opposition